2697474 - Study on the relationship between HER2 mutation, amplification and expression levels and drug sensitivity of trastuzumab deruxtecan in pancancerous solid tumors - OmicsDI

Clinical

Dataset Information

Study on the relationship between HER2 mutation, amplification and expression levels and drug sensitivity of trastuzumab deruxtecan in pancancerous solid tumors

ABSTRACT: Interventions: experimental group:DS8201a ;control group:DMSO Primary outcome(s): HER2 Study Design: Non randomized control

DISEASE(S): Breast Cancer, Gastric And Colorectal Cancer, And Non-small Lumg Cancer

PROVIDER: 2697474 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR